Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by AXS Investments LLC

AXS Investments LLC lowered its position in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 12.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,050 shares of the biopharmaceutical company’s stock after selling 295 shares during the period. AXS Investments LLC’s […]

Related Keywords

United States ,Merdad Parsey ,Complera Eviplera ,Gilead Sciences Company Profile ,Nasdaq ,Gilead Sciences Inc ,Wetzel Investment Advisors Inc ,News Ratings For Gilead Sciences Daily ,Altfest Lj Co ,Hermes Inc ,Cantor Fitzgerald ,Axs Investments ,Charles Schwab Investment Management Inc ,Gilead Sciences Trading Down ,Securities Exchange Commission ,Gilead Sciences ,Gilead Sciences Dividend Announcement ,Quarter For Gilead Sciences ,Free Report ,Schwab Investment Management ,Investment Advisors ,Sciences Trading Down ,Get Free Report ,Visit Holdingschannel ,Gilead Sciences Daily ,